Fabry's disease historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{Fabry's disease}}
{{Fabry's disease}}


{{CMG}}
{{CMG}} {{Neepa Shah}}


Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.


==Historical Perspective==
==Historical Perspective==
It was named after Johannes Fabry.<ref>{{WhoNamedIt|synd|1761}}</ref>
It was named after Johannes Fabry and William Anderson in 1981.
=== Discovery ===
 
*In 1878 Cottle first described in the St George Hospital Reports about angiokeratoma- dermatological manifestations of Fabry's disease.
*In 1952 it was recognized that Fabry's disease is due to abnormal storage of glycolipids in blood vessels and other organs.
*In 1960 it was established that Fabry's disease is an X- linked disease due to deficiency of alpha-galactosidase.
*In 1985 Crocker mentioned about angiokeratoma in "Diseases of the Skin"
*In 1986 and 1989 Colcott Fox published more cases with angiokeratomas.
*In 1965 Ken Hashimoto published electron microscopic findings. [33][34]
*In 2001 Specific treatment for Fabry's disease was introduced.{19}{22}
 
 
 
 
<ref>{{WhoNamedIt|synd|1761}}</ref>.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Pediatrics]]

Revision as of 14:25, 22 July 2020

Fabry's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fabry's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fabry's disease historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fabry's disease historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fabry's disease historical perspective

CDC on Fabry's disease historical perspective

Fabry's disease historical perspective in the news

Blogs on Fabry's disease historical perspective

Directions to Hospitals Treating Fabry's disease

Risk calculators and risk factors for Fabry's disease historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Neepa Shah, M.B.B.S.[2]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Historical Perspective

It was named after Johannes Fabry and William Anderson in 1981.

Discovery

  • In 1878 Cottle first described in the St George Hospital Reports about angiokeratoma- dermatological manifestations of Fabry's disease.
  • In 1952 it was recognized that Fabry's disease is due to abnormal storage of glycolipids in blood vessels and other organs.
  • In 1960 it was established that Fabry's disease is an X- linked disease due to deficiency of alpha-galactosidase.
  • In 1985 Crocker mentioned about angiokeratoma in "Diseases of the Skin"
  • In 1986 and 1989 Colcott Fox published more cases with angiokeratomas.
  • In 1965 Ken Hashimoto published electron microscopic findings. [33][34]
  • In 2001 Specific treatment for Fabry's disease was introduced.{19}{22}



[1].

References